Relapse of immune thrombocytopenia after receiving AstraZeneca coronavirus disease-2019 vaccine: A case report

Saba Seyedi; Shadan Navid; Zahra Saadatian

doi:10.1002/ccr3.7872

Relapse of immune thrombocytopenia after receiving AstraZeneca coronavirus disease-2019 vaccine: A case report

Clin Case Rep. 2023 Sep 4;11(9):e7872. doi: 10.1002/ccr3.7872. eCollection 2023 Sep.

Authors

Saba Seyedi¹, Shadan Navid², Zahra Saadatian³

Affiliations

¹ Department of Medical Laboratory Sciences, School of Medicine Gonabad University of Medical Sciences Gonabad Iran.
² Department of Anatomy, Faculty of Medicine, Social Determinants of Health Research Center Gonabad University of Medical Sciences Gonabad Iran.
³ Department of Physiology, Faculty of Medicine, Infectious Diseases Research Center Gonabad University of Medical Sciences Gonabad Iran.

Abstract

Immune thrombocytopenic purpura (ITP) is an autoimmune disease characterized by a low platelets count. In this paper, we present a case of ITP relapse in a 31-year-old Iranian woman as a potential complication of the AstraZeneca vaccine.

Keywords: AZD1222; AstraZeneca; COVID‐19; ChAdOx1 nCoV‐19; case report; immune thrombocytopenic purpura.

Publication types

Case Reports